Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy

Fucoidans, discovered in 1913, are fucose-rich sulfated polysaccharides extracted mainly from brown seaweed. These versatile and nontoxic marine-origin heteropolysaccharides have a wide range of favorable biological activities, including antitumor, immunomodulatory, antiviral, antithrombotic, antico...

Full description

Bibliographic Details
Main Authors: Yani Li, Eileen McGowan, Size Chen, Jerran Santos, Haibin Yin, Yiguang Lin
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/21/2/128
_version_ 1797619707084275712
author Yani Li
Eileen McGowan
Size Chen
Jerran Santos
Haibin Yin
Yiguang Lin
author_facet Yani Li
Eileen McGowan
Size Chen
Jerran Santos
Haibin Yin
Yiguang Lin
author_sort Yani Li
collection DOAJ
description Fucoidans, discovered in 1913, are fucose-rich sulfated polysaccharides extracted mainly from brown seaweed. These versatile and nontoxic marine-origin heteropolysaccharides have a wide range of favorable biological activities, including antitumor, immunomodulatory, antiviral, antithrombotic, anticoagulant, antithrombotic, antioxidant, and lipid-lowering activities. In the early 1980s, fucoidans were first recognized for their role in supporting the immune response and later, in the 1990s, their effects on immune potentiation began to emerge. In recent years, the understanding of the immunomodulatory effects of fucoidan has expanded significantly. The ability of fucoidan(s) to activate CTL-mediated cytotoxicity against cancer cells, strong antitumor property, and robust safety profile make fucoidans desirable for effective cancer immunotherapy. This review focusses on current progress and understanding of the immunopotentiation activity of various fucoidans, emphasizing their relevance to cancer immunotherapy. Here, we will discuss the action of fucoidans in different immune cells and review how fucoidans can be used as adjuvants in conjunction with immunotherapeutic products to improve cancer treatment and clinical outcome. Some key rationales for the possible combination of fucoidans with immunotherapy will be discussed. An update is provided on human clinical studies and available registered cancer clinical trials using fucoidans while highlighting future prospects and challenges.
first_indexed 2024-03-11T08:30:40Z
format Article
id doaj.art-a9e185a3c0cd4cb998421deb35d6bfd5
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-11T08:30:40Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-a9e185a3c0cd4cb998421deb35d6bfd52023-11-16T21:48:10ZengMDPI AGMarine Drugs1660-33972023-02-0121212810.3390/md21020128Immunopotentiating Activity of Fucoidans and Relevance to Cancer ImmunotherapyYani Li0Eileen McGowan1Size Chen2Jerran Santos3Haibin Yin4Yiguang Lin5School of Life Science, Faculty of Science, University of Technology Sydney, P.O. Box 123, Broadway, NSW 2007, AustraliaSchool of Life Science, Faculty of Science, University of Technology Sydney, P.O. Box 123, Broadway, NSW 2007, AustraliaDepartment of Immuno-Oncology, First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, ChinaAdvanced Tissue Engineering and Stem Cell Biology Group, Faculty of Science, University of Technology Sydney, P.O. Box 123, Broadway, NSW 2007, AustraliaResearch & Development Division, Guangzhou Anjie Biomedical Technology Co., Limited, Guangzhou 510535, ChinaSchool of Life Science, Faculty of Science, University of Technology Sydney, P.O. Box 123, Broadway, NSW 2007, AustraliaFucoidans, discovered in 1913, are fucose-rich sulfated polysaccharides extracted mainly from brown seaweed. These versatile and nontoxic marine-origin heteropolysaccharides have a wide range of favorable biological activities, including antitumor, immunomodulatory, antiviral, antithrombotic, anticoagulant, antithrombotic, antioxidant, and lipid-lowering activities. In the early 1980s, fucoidans were first recognized for their role in supporting the immune response and later, in the 1990s, their effects on immune potentiation began to emerge. In recent years, the understanding of the immunomodulatory effects of fucoidan has expanded significantly. The ability of fucoidan(s) to activate CTL-mediated cytotoxicity against cancer cells, strong antitumor property, and robust safety profile make fucoidans desirable for effective cancer immunotherapy. This review focusses on current progress and understanding of the immunopotentiation activity of various fucoidans, emphasizing their relevance to cancer immunotherapy. Here, we will discuss the action of fucoidans in different immune cells and review how fucoidans can be used as adjuvants in conjunction with immunotherapeutic products to improve cancer treatment and clinical outcome. Some key rationales for the possible combination of fucoidans with immunotherapy will be discussed. An update is provided on human clinical studies and available registered cancer clinical trials using fucoidans while highlighting future prospects and challenges.https://www.mdpi.com/1660-3397/21/2/128fucoidanseaweedimmunopotentiationimmunomodulatoryimmunotherapycancer treatment
spellingShingle Yani Li
Eileen McGowan
Size Chen
Jerran Santos
Haibin Yin
Yiguang Lin
Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy
Marine Drugs
fucoidan
seaweed
immunopotentiation
immunomodulatory
immunotherapy
cancer treatment
title Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy
title_full Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy
title_fullStr Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy
title_full_unstemmed Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy
title_short Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy
title_sort immunopotentiating activity of fucoidans and relevance to cancer immunotherapy
topic fucoidan
seaweed
immunopotentiation
immunomodulatory
immunotherapy
cancer treatment
url https://www.mdpi.com/1660-3397/21/2/128
work_keys_str_mv AT yanili immunopotentiatingactivityoffucoidansandrelevancetocancerimmunotherapy
AT eileenmcgowan immunopotentiatingactivityoffucoidansandrelevancetocancerimmunotherapy
AT sizechen immunopotentiatingactivityoffucoidansandrelevancetocancerimmunotherapy
AT jerransantos immunopotentiatingactivityoffucoidansandrelevancetocancerimmunotherapy
AT haibinyin immunopotentiatingactivityoffucoidansandrelevancetocancerimmunotherapy
AT yiguanglin immunopotentiatingactivityoffucoidansandrelevancetocancerimmunotherapy